![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.75 | 2.75% | 28.00 | 27.60 | 28.00 | 27.80 | 27.25 | 27.25 | 2,193,935 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 56.04M | 16.12M | 0.0237 | 11.73 | 185.4M |
TIDMRVG
RNS Number : 9318C
Retroscreen Virology Group PLC
08 May 2012
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) -------------------------------------------------------------------------------------------- 1. Identity of the issuer or Retroscreen Virology PLC the underlying issuer of existing shares to which voting rights are attached: (ii) ------------------------------------------------------------- ----------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): -------------------------------------------------------------------------------------------- An acquisition or disposal of voting rights ---------------------------------------------------------------- -------------------------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached ---------------------------------------------------------------- -------------------------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments ---------------------------------------------------------------- -------------------------- An event changing the breakdown of voting rights ---------------------------------------------------------------- -------------------------- Other (please specify): ----------------------------------------------------------- --- -------------------------- 3. Full name of person(s) BlackRock, Inc. subject to the notification obligation: (iii) ----------------------------------------------------------- ------------------------------- 4. Full name of shareholder(s) (if different from 3.):(iv) ----------------------------------------------------------- ------------------------------- 5. Date of the transaction 3(rd) May 2012 and date on which the threshold is crossed or reached: (v) ----------------------------------------------------------- ------------------------------- 6. Date on which issuer 8(th) May 2012 notified: ----------------------------------------------------------- ------------------------------- 7. Threshold(s) that is/are Holding has gone above 5% crossed or reached: (vi, vii) ----------------------------------------------------------- ------------------------------- 8. Notified details: ----------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares (viii, ix) ----------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after of to the triggering the triggering transaction shares transaction if possible using the ISIN CODE -------------- ------------------------------- ---------------------------------------------------------- Number Number Number Number of % of voting of of of voting rights (x) Shares Voting shares rights Rights -------------- -------------- --------------- ------------- ---------------------- ------------------- Direct Direct Indirect Direct Indirect (xi) (xii) -------------- ------------ ------------- ------------- ---------- ---------- -------- --------- GB00B6ZM0X53 N/A N/A N/A N/A 2,187,500 N/A 5.34% -------------- --------------- ------------- ---------- ---------- -------- --------- B: Qualifying Financial Instruments ----------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------- Type of Expiration Exercise/ Number of % of voting financial date Conversion voting rights instrument (xiii) Period (xiv) rights that may be acquired if the instrument is exercised/ converted. ---------------- -------------- ------------------------------ -------------------- ------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) ----------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ----------------------------------------------------------------------------------------------------------- Type of Exercise Expiration Exercise/ Number of % of voting financial price date Conversion voting rights rights (xix, instrument (xvii) period instrument xx) (xviii) refers to --------------- -------------- -------------- -------------- --------------------- ------------------- Nominal Delta --------------- -------------- -------------- -------------- --------------------- -------- --------- Total (A+B+C) ----------------------------------------------------------------------------------------------------------- Number of voting rights Percentage of voting rights ------------------------------------------------ --------------------------------------------------------- 2,187,500 5.34% ------------------------------------------------ --------------------------------------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) --------------------------------------------------------------------------------------------- BlackRock Investment Management (UK) Limited - 2,187,500 (5.34%) Proxy Voting: --------------------------------------------------------------------------------------------- 10. Name of the proxy holder: ------------------------------------------------------------- ------------------------------ 11. Number of voting rights proxy holder will cease to hold: ------------------------------------------------------------- ------------------------------ 12. Date on which proxy holder will cease to hold voting rights: ------------------------------------------------------------- ------------------------------ BlackRock Threshold Reporting 13. Additional information: Team ------------------------------------------------------------- ------------------------------ 14. Contact name: Andrew Manchester ------------------------------------------------------------- ------------------------------ 15. Contact telephone number: 020 7743 5773 ------------------------------------------------------------- ------------------------------ Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in share A: Identity of the persons or legal entity subject to the notification obligation ------------------------------------------------------------------------------------- Full name BlackRock, Inc. (including legal form of legal entities) ------------------------------------ ----------------------------------------------- Contact address 12 Throgmorton Avenue, London, (registered office for legal EC2N 2DL entities) ------------------------------------ ----------------------------------------------- Phone number & email 020 7743 5773; andrew.manchester@blackrock.com ------------------------------------ ----------------------------------------------- Other useful information Andrew Manchester (at least legal representative for legal persons) ------------------------------------ ----------------------------------------------- B: Identity of the notifier, if applicable ------------------------------------------------------------------------------------- Full name ------------------------------------ ----------------------------------------------- Contact address ------------------------------------ ----------------------------------------------- Phone number & email ------------------------------------ ----------------------------------------------- Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) ------------------------------------ ----------------------------------------------- C: Additional information ------------------------------------------------------------------------------------- For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLAPMRTMBAMBPT
1 Year Hvivo Chart |
1 Month Hvivo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions